195 related articles for article (PubMed ID: 8304756)
1. p53 oncoprotein expression and proliferation index in keratoacanthoma and squamous cell carcinoma.
Kerschmann RL; McCalmont TH; LeBoit PE
Arch Dermatol; 1994 Feb; 130(2):181-6. PubMed ID: 8304756
[TBL] [Abstract][Full Text] [Related]
2. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.
Batinac T; Zamolo G; Coklo M; Hadzisejdic I; Stemberger C; Zauhar G
Pathol Res Pract; 2006; 202(8):599-607. PubMed ID: 16781827
[TBL] [Abstract][Full Text] [Related]
3. Cell apoptosis as assessed by M30 expression in keratoacanthoma and squamous cell carcinoma.
Batinac T; Zamolo G; Brumini G; Biljan D; Petranović D; Troselj-Vukić B
Coll Antropol; 2008 Jun; 32(2):499-504. PubMed ID: 18756900
[TBL] [Abstract][Full Text] [Related]
4. Immunoexpression of Bcl-x in squamous cell carcinoma and keratoacanthoma: differences in pattern and correlation with pathobiology.
Tan KB; Lee YS
Histopathology; 2009 Sep; 55(3):338-45. PubMed ID: 19723149
[TBL] [Abstract][Full Text] [Related]
5. The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma.
Mukunyadzi P; Sanderson RD; Fan CY; Smoller BR
Mod Pathol; 2002 Jan; 15(1):45-9. PubMed ID: 11796840
[TBL] [Abstract][Full Text] [Related]
6. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
Sakiz D; Turkmenoglu TT; Kabukcuoglu F
Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
[TBL] [Abstract][Full Text] [Related]
7. Comparison of oncostatin M expression in keratoacanthoma and squamous cell carcinoma.
Tran TA; Ross JS; Sheehan CE; Carlson JA
Mod Pathol; 2000 Apr; 13(4):427-32. PubMed ID: 10786810
[TBL] [Abstract][Full Text] [Related]
8. Differences between keratoacanthoma and squamous cell carcinoma using TGF-alpha.
Cabrijan L; Lipozencić J; Batinac T; Lenković M; Zgombić ZS
Coll Antropol; 2013 Mar; 37(1):147-50. PubMed ID: 23697265
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic analysis of the p53 gene in non-melanoma skin cancer and correlation with apoptosis and cell proliferation.
Stratigos AJ; Kapranos N; Petrakou E; Anastasiadou A; Pagouni A; Christofidou E; Petridis A; Papadopoulos O; Kokka E; Antoniou C; Georgala S; Katsambas AD
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):180-6. PubMed ID: 15752287
[TBL] [Abstract][Full Text] [Related]
10. Assessment of syndecan-1 (CD138) and Ki-67 expression for differentiating keratoacanthoma and squamous cell carcinoma.
Lammoglia-Ordiales L; Toussaint-Caire S; Contreras-Barrera M; Fonte-Avalos V; Rodriguez-Carreón AA; Rivera-Macias S; Dominguez-Cherit J
J Drugs Dermatol; 2013 Mar; 12(3):e53-8. PubMed ID: 23545927
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical staining for the differentiation of subungual keratoacanthoma from subungual squamous cell carcinoma.
Connolly M; Narayan S; Oxley J; de Berker DA
Clin Exp Dermatol; 2008 Aug; 33(5):625-8. PubMed ID: 18616725
[TBL] [Abstract][Full Text] [Related]
12. The nuclear factor kappa B p50 subunit and cortactin as markers to distinguish between keratoacanthoma and well-differentiated squamous cell carcinoma.
Fujii M; Honma M; Takahashi H; Ishida-Yamamoto A; Iizuka H
Clin Exp Dermatol; 2011 Oct; 36(7):788-92. PubMed ID: 21883393
[TBL] [Abstract][Full Text] [Related]
13. Expression of class II beta-tubulin in non-melanoma cutaneous tumors.
Roh JY; Kee SH; Choi JW; Lee JH; Lee JH; Lee ES; Kim YS
J Cutan Pathol; 2007 Feb; 34(2):166-73. PubMed ID: 17244029
[TBL] [Abstract][Full Text] [Related]
14. Stromal CD10 expression, as well as increased dermal macrophages and decreased Langerhans cells, are associated with malignant transformation of keratinocytes.
Takahara M; Chen S; Kido M; Takeuchi S; Uchi H; Tu Y; Moroi Y; Furue M
J Cutan Pathol; 2009 Jun; 36(6):668-74. PubMed ID: 19515046
[TBL] [Abstract][Full Text] [Related]
15. Expression profiles of p63, p53, survivin, and hTERT in skin tumors.
Park HR; Min SK; Cho HD; Kim KH; Shin HS; Park YE
J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709
[TBL] [Abstract][Full Text] [Related]
16. The multi-step process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1.
Burnworth B; Arendt S; Muffler S; Steinkraus V; Bröcker EB; Birek C; Hartschuh W; Jauch A; Boukamp P
Eur J Cell Biol; 2007 Dec; 86(11-12):763-80. PubMed ID: 17198740
[TBL] [Abstract][Full Text] [Related]
17. Differential diagnosis of keratoacanthoma and squamous cell carcinoma of the epidermis by MIB-1 immunohistometry.
Biesterfeld S; Josef J
Anticancer Res; 2002; 22(5):3019-23. PubMed ID: 12530035
[TBL] [Abstract][Full Text] [Related]
18. Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors.
Cain CT; Niemann TH; Argenyi ZB
Am J Dermatopathol; 1995 Aug; 17(4):324-31. PubMed ID: 8600793
[TBL] [Abstract][Full Text] [Related]
19. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma.
Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Tomoyose T; Takano H; Funaki K; Fukuyama H; Takahashi T; Sakoda S
J Oral Pathol Med; 2005 Nov; 34(10):602-7. PubMed ID: 16202080
[TBL] [Abstract][Full Text] [Related]
20. Expression of apoptotic and cell proliferation regulatory proteins in keratoacanthomas and squamous cell carcinomas of the skin.
Ribeiro D; Narikawa S; Marques ME
Pathol Res Pract; 2008; 204(2):97-104. PubMed ID: 18079070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
